These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29548605)

  • 1. A recombinant trivalent vaccine candidate against human adenovirus types 3, 7, and 55.
    Liu T; Zhou Z; Tian X; Liu W; Xu D; Fan Y; Liao J; Gu S; Li X; Zhou R
    Vaccine; 2018 Apr; 36(16):2199-2206. PubMed ID: 29548605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions.
    Qiu H; Li X; Tian X; Zhou Z; Xing K; Li H; Tang N; Liu W; Bai P; Zhou R
    J Virol; 2012 Aug; 86(15):7964-75. PubMed ID: 22623776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of neutralizing monoclonal antibodies against a conformational epitope of human adenovirus type 7 (HAdv-7) incorporated in capsid encoded in a HAdv-3-based vector.
    Liu M; Tian X; Li X; Zhou Z; Li C; Zhou R
    PLoS One; 2014; 9(7):e103058. PubMed ID: 25054273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing epitopes mapping of human adenovirus type 14 hexon.
    Ma Q; Tian X; Jiang Z; Huang J; Liu Q; Lu X; Luo Q; Zhou R
    Vaccine; 2015 Nov; 33(48):6659-65. PubMed ID: 26546264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tetravalent vaccine comprising hexon-chimeric adenoviruses elicits balanced protective immunity against human adenovirus types 3, 7, 14 and 55.
    Tian X; Jiang Z; Fan Y; Qiu S; Zhang L; Li X; Zhou Z; Liu T; Ma Q; Lu X; Zhong B; Zhou R
    Antiviral Res; 2018 Jun; 154():17-25. PubMed ID: 29626491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Critical and Conformational Neutralizing Epitope in Human Adenovirus Type 4 Hexon.
    Tian X; Qiu H; Zhou Z; Wang S; Fan Y; Li X; Chu R; Li H; Zhou R; Wang H
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Construction and Characterization of a Novel Recombinant Attenuated and Replication-Deficient Candidate Human Adenovirus Type 3 Vaccine: "Adenovirus Vaccine Within an Adenovirus Vector".
    Yan Y; Jing S; Feng L; Zhang J; Zeng Z; Li M; Zhao S; Ou J; Lan W; Guan W; Wu X; Wu J; Seto D; Zhang Q
    Virol Sin; 2021 Jun; 36(3):354-364. PubMed ID: 32458297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Worldwide increased prevalence of human adenovirus type 3 (HAdV-3) respiratory infections is well correlated with heterogeneous hypervariable regions (HVRs) of hexon.
    Haque E; Banik U; Monowar T; Anthony L; Adhikary AK
    PLoS One; 2018; 13(3):e0194516. PubMed ID: 29590206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis reveals four major hexon variants of human adenovirus type-3 (HAdV-3) as the potential strains for development of vaccine and siRNA-based therapeutics against HAdV-3 respiratory infections.
    Panda S; Banik U; Adhikary AK
    Infect Genet Evol; 2020 Nov; 85():104439. PubMed ID: 32585339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bivalent live-attenuated vaccine candidate elicits protective immunity against human adenovirus types 4 and 7.
    Guo J; Zhang Y; Zhang Y; Zhang C; Zhu C; Xing M; Wang X; Zhou D
    Emerg Microbes Infect; 2021 Dec; 10(1):1947-1959. PubMed ID: 34520320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping the epitope of neutralizing monoclonal antibodies against human adenovirus type 3.
    Tian X; Liu M; Su X; Jiang Z; Ma Q; Liao X; Li X; Zhou Z; Li C; Zhou R
    Virus Res; 2015 Oct; 208():66-72. PubMed ID: 26071383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel human monoclonal antibody potently neutralizes human adenovirus serotype 7 by primarily targeting the adenovirus hexon protein.
    Lu J; Wang R; Huang Y; Yu Y; Zhou X; Huang P; Yang Z
    Virology; 2020 Apr; 543():20-26. PubMed ID: 32056843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of 65 years of human adenovirus seroprevalence.
    Mennechet FJD; Paris O; Ouoba AR; Salazar Arenas S; Sirima SB; Takoudjou Dzomo GR; Diarra A; Traore IT; Kania D; Eichholz K; Weaver EA; Tuaillon E; Kremer EJ
    Expert Rev Vaccines; 2019 Jun; 18(6):597-613. PubMed ID: 31132024
    [No Abstract]   [Full Text] [Related]  

  • 14. Recombinant influenza virus carrying human adenovirus epitopes elicits protective immunity in mice.
    Yang P; Li T; Liu N; Gu H; Han L; Zhang P; Li Z; Wang Z; Zhang S; Wang X
    Antiviral Res; 2015 Sep; 121():145-51. PubMed ID: 26112646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral Vaccination with Replication-Competent Adenovirus in Mice Reveals Dissemination of the Viral Vaccine beyond the Gastrointestinal Tract.
    Goffin E; Javaux J; Destexhe E; Pretto CD; Spindler KR; Machiels B; Gillet L
    J Virol; 2019 Jul; 93(13):. PubMed ID: 30996103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of adenovirus neutralizing antigens using capsid chimeric viruses.
    Liu T; Fan Y; Li X; Gu S; Zhou Z; Xu D; Qiu S; Li C; Zhou R; Tian X
    Virus Res; 2018 Sep; 256():100-106. PubMed ID: 30096411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping and characterization of a neutralizing monoclonal antibody against human adenovirus type 3.
    Tian X; Li C; Xue C; Li X; Zhou Z; Zhou R
    Virus Res; 2013 Nov; 177(2):189-93. PubMed ID: 24018287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Murine Monoclonal Antibody With Potent Neutralization Ability Against Human Adenovirus 7.
    Wang R; Lu J; Zhou Q; Chen L; Huang Y; Yu Y; Yang Z
    Front Cell Infect Microbiol; 2019; 9():417. PubMed ID: 31867291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and characterization of a recombinant human adenovirus type 3 vector containing two foreign neutralizing epitopes in hexon.
    Xue C; Tian X; Li X; Zhou Z; Su X; Zhou R
    Virus Res; 2014 Apr; 183():67-74. PubMed ID: 24518297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsid display of a conserved human papillomavirus L2 peptide in the adenovirus 5 hexon protein: a candidate prophylactic hpv vaccine approach.
    Wu WH; Alkutkar T; Karanam B; Roden RB; Ketner G; Ibeanu OA
    Virol J; 2015 Sep; 12():140. PubMed ID: 26362430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.